Morpholine‐Facilitated Enrichment‐Triggered Delivery of Carbon Monoxide to Lysosome: A Feasibility Study
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Ravi Tripathi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Morpholines, Lysosomes, Carbon Monoxide, Prodrugs. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Targeted delivery of carbon monoxide (CO) prodrugs holds important therapeutic potential for various applications. Along this line, we developed an enrichment‐triggered release (ETR) approach for activating 2‐component (a diene and a dienophile) CO prodrugs upon enrichment in the mitochondrion, giving a “one stone, two birds” approach. Herein, we aim to broaden the scope of application to targeted delivery to the lysosome. We tethered a CO prodrug pair, a diene and a dienophile, with morpholine, a lysosomal targeting moiety. Several analogs were synthesized to tune the second‐order rate constants ( k 2 ) to a desirable range. We chose two pairs of the prodrugs with different second‐order rate constants (0.087 and 0.21 M −1 s −1 ) to further study their enrichment and CO release ability. For one pair, LC–MS experiments revealed > 13‐fold enrichment of the morpholine‐conjugated CO prodrug pair compared to non‐targeted controls in HeLa cells. Fluorescence studies demonstrated the same enrichment and co‐localization of LysoTracker. For the second pair, conjugation with morpholine did not lead to improved enrichment in the lysosome. This study represents the first demonstration of lysosome‐targeted delivery of CO. However, our findings also note the nonuniversal nature for a morpholine moiety to lead to lysosomal enrichment. The modest magnitude of enrichment also means that this method may only be applicable for targeted delivery of a highly potent drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia, USA.
ORCID-Profile: Ravi Tripathi, Dongning Liu, Qiyue Mao
Förderung
- NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Tripathi, R., Liu, D., Yang, X., Yang, C., Lu, W., Mao, Q., & Wang, B. (2025). Morpholine‐Facilitated Enrichment‐Triggered Delivery of Carbon Monoxide to Lysosome: A Feasibility Study. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70168
Vancouver
Tripathi R, Liu D, Yang X, Yang C, Lu W, Mao Q, et al. Morpholine‐Facilitated Enrichment‐Triggered Delivery of Carbon Monoxide to Lysosome: A Feasibility Study. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70168
BibTeX
@article{Tripathi2025,
author = {Tripathi, Ravi and Liu, Dongning and Yang, Xiaoxiao and Yang, Ce and Lu, Wen and Mao, Qiyue and Wang, Binghe},
title = {Morpholine‐Facilitated Enrichment‐Triggered Delivery of Carbon Monoxide to Lysosome: A Feasibility Study},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70168}
}
EUVIMED